KLRD1 and neoplasm: γδ T cells cells function in both innate and adaptive immunity, directly targeting tumor cells independent of MHC presentation and mediating antitumor activity through NK cell receptors, ADCC, and cytokine secretion (e.g., IFN-γ, TNF-α), although their efficacy is often limited by complex tumor immune evasion mechanisms (55).